- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01980563
Optimizing Ovarian Stimulation for IVF and ICSI
November 4, 2013 updated by: University Hospital, Ghent
Monitoring ovarian stimulation for in vitro fertilization (IVF) and intracytoplasmatic sperm injection (ICSI) can be simplified by reducing the procedure to measuring follicles by ultrasound.
Proponents of a simplified procedure claim that the procedure can be reduced to simple monitoring by ultrasound while maintaining results (numbers of mature oocytes, percentage of pregnancy and live birth rates).
On the other hand simultaneous blood sampling for measuring hormone levels is still the state of the art in many clinics.
A large review (Cochrane review) stated that "although there was no clear evidence for a better outcome, combined cycle monitoring was still recommended until it could be proven that ovarian hyperstimulation can be avoided without hormonal monitoring".
Investigators therefore perform a study that compares the results between 2 groups: those with ultrasound monitoring and those with combined monitoring.
Deciding when to plan the retrieval of the oocytes can depend on subtle differences in the number of large follicles measured by ultrasound, but also on hormonal levels in the blood of the patient.
Therefore the investigators planned a randomized study in the group of patients with combined monitoring.
The investigators examined if delaying the moment for planning the moment of oocyte retrieval by 24 hours had any effect on the number of mature oocytes and pregnancy rates and what the effect of rising progesterone levels might be.
The investigators hypothesis was that combined monitoring could lead to better results since recent studies have thought that rising progesterone levels, if found, have a negative impact on pregnancy rates.
On the other hand the investigators expect to find that waiting for larger follicles in cases with normal progesterone levels lead to a better oocyte yield.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
416
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Ghent, Belgium, 9000
- University Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 45 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
inclusion criteria:
- absence of ovarian cysts
- both ovaries present
exclusion criteria:
- ovarian cysts
- not both ovaries present
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: ultrasound
|
|
Active Comparator: combined monitoring
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The number of mature oocytes obtained.
Time Frame: 1 day
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The number of fertilized oocytes/good quality embryos
Time Frame: at the moment of egg retrieval up to embryo transfer, assessed up to 100 months
|
at the moment of egg retrieval up to embryo transfer, assessed up to 100 months
|
Pregnancy rate
Time Frame: 12 months after egg retrieval
|
12 months after egg retrieval
|
clinical pregnancy rate
Time Frame: 12 months after egg retrieval
|
12 months after egg retrieval
|
ongoing pregnancy rate
Time Frame: 12 months after egg retrieval
|
12 months after egg retrieval
|
live birth rate for each individual transferred embryo
Time Frame: 12 months after egg retrieval
|
12 months after egg retrieval
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Frank Vandekerckhove, MD, Fertility Clinic
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2011
Primary Completion (Actual)
December 1, 2011
Study Completion (Actual)
December 1, 2012
Study Registration Dates
First Submitted
October 24, 2013
First Submitted That Met QC Criteria
November 4, 2013
First Posted (Estimate)
November 11, 2013
Study Record Updates
Last Update Posted (Estimate)
November 11, 2013
Last Update Submitted That Met QC Criteria
November 4, 2013
Last Verified
November 1, 2013
More Information
Terms related to this study
Other Study ID Numbers
- EC/2010/367
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Efficiency in Terms of Mature Oocyte Yield
-
University of ZurichCompletedRegeneration Potential of Healthy Old Men in Terms of Satellite Cell ActivationSwitzerland
-
Centre Hospitalier le MansCompletedNon-inferiority, in Terms of Extubation Failure, Continuation of Enteral Nutrition Before Extubation Versus Gastric Vacuity Peri-extubationFrance, Guadeloupe
-
University Hospital, Gentofte, CopenhagenUnknownReduction of Psoriasis Following Liraglutide Therapy in Terms of PASI and DLQIDenmark
-
Alternative Research InitiativeFoundation for a Smoke-Free WorldNot yet recruitingRole of Tobacco Harm Reduction in Smoking Cessation | Efficiency and Efficacy of E-cigarettes and Nicotine Pouches | Adverse Effect of E-cigarettes and Nicotine PouchesPakistan
-
All India Institute of Medical Sciences, BhubaneswarNot yet recruitingThe Goal of This Trial is to to Compare the Effect of Risperidone vs Aripiprazole in Terms of Change in Serum Glutathione Level
-
InvestigatorUrologyIBSALInstituto de Investigación Biomédica de SalamancaUnknownEstablish the Efficacy Between the Four Schemes in Terms of the Aggressiveness of the Tumors According to the Gleason Classification | Establish the Efficacy Between the Four Schemes in Terms of Morbidity Associated With the Technique | Establish the Efficacy Between the Four Schemes... and other conditionsSpain
-
China Academy of Chinese Medical SciencesUnknownEfficiency of Genuine Regional and Non-genuine Regional Rhizoma Atractylodis in Treating FD
-
Heidelberg UniversityUnknownSolitary Pulmonary Nodule | Yield of Cryo Biopsy in Lung CancerGermany
-
Hospital St. Joseph, Marseille, FranceWithdrawnFibrillation, Atrial | To Evaluate the Intraoperative Efficiency of the AIFIB Software in the Detection of Atrial Fibrillation Driver During an Ablation ProcedureFrance, Netherlands
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)TerminatedAcute Lymphoblastic Leukemia | Mantle Cell Lymphoma | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Plasma Cell Myeloma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Minimal Residual Disease | Therapy-Related Acute Myeloid Leukemia | Therapy-Related Myelodysplastic... and other conditionsUnited States
Clinical Trials on ultrasound
-
Ahram Canadian UniversityCompletedCarpal Tunnel Syndrome | Median Neuropathy, Carpal TunnelEgypt
-
Eskisehir Osmangazi UniversityCompletedCarpal Tunnel Syndrome
-
Cairo UniversityUnknown
-
Ohio State University Comprehensive Cancer CenterWithdrawn
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Withdrawn
-
Mayo ClinicNational Cancer Institute (NCI); National Institute for Biomedical Imaging...RecruitingBreast CarcinomaUnited States
-
Bursa Yüksek İhtisas Education and Research HospitalNot yet recruitingShoulder Impingement Syndrome | Shoulder Pain
-
John PelleritoGeneral ElectricActive, not recruiting
-
Oregon Health and Science UniversityRecruiting
-
Yale UniversityCompletedPneumonia | Pulmonary Edema | DyspneaUnited States